EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study

Jinzhao Xie, Xu Wang, Xinran Wang, Jinghua Li, Yusheng Jie, Yuantao Hao, Jing Gu

Global Health Research and Policy · 2024

DOI: 10.1186/s41256-024-00345-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Health Research and Policy, 2024. Verfasst von Jinzhao Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Diabetes Mellitus, Type 2, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province, National Major Science and Technology Projects of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

China bears a high burden of both hepatitis B virus (HBV) infection and type 2 diabetes mellitus (T2DM). T2DM accelerates the progression of liver disease among individuals infected with HBV. This study aims to assess the excess disease burden caused by comorbid T2DM among HBV-infected individuals in China.

Methods

We estimated the disease burden of HBV and its complications in China from 2006 to 2030 using individual-based Markov models. The baseline population consisted of 93 million HBV-infected individuals derived from the 2006 National Serological Epidemiological Survey. We developed two models: one incorporated the impact of T2DM on the disease progression of HBV infection, while the other did not consider the impact of T2DM. By comparing the outcomes between these two models, we estimated the excess disease burden attributable to comorbid T2DM among HBV-infected individuals.

Results

The incidence of severe HBV complications, including cirrhosis, hepatocellular carcinoma (HCC), and liver-related deaths, exhibited an increasing trend from 2006 to 2030 among the Chinese HBV-infected population. Comorbid T2DM increased the annual incidence and cumulative cases of severe HBV complications. From 2006 to 2022, comorbid T2DM caused 791,000 (11.41%), 244,000 (9.27%), 377,000 (8.78%), and 796,000 (12.19%) excess cases of compensated cirrhosis, decompensated cirrhosis, HCC, and liver-related deaths, respectively. From 2023 to 2030, comorbid T2DM is projected to result in an 8.69% excess in severe HBV complications and an 8.95% increase in liver-related deaths. Among individuals aged 60 and older at baseline, comorbid T2DM led to a 21.68% excess in severe HBV complications and a 28.70% increase in liver-related deaths from 2006 to 2022, with projections indicating a further 20.76% increase in severe HBV complications and an 18.31% rise in liver-related deaths over the next seven years.

Conclusions

Comorbid T2DM imposes a substantial disease burden on individuals with HBV infection in China. Healthcare providers and health policymakers should develop and implement tailored strategies for the effective management and control of T2DM in individuals with HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicDiabetes Mellitus, Type 2Carcinoma, HepatocellularLiver NeoplasmsHepatitis BHumansMiddle AgedAgedHepatitis B virusLiver CirrhosisChinaCost of Illness

Stichwörter der Autor:innen

ChinaComorbidityDiabetes mellitusDisease burdenHepatitis B virus infectionMarkov

Autor:innen und Institutionen

  • Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China.
  • Sun Yat-sen Global Health Institute, School of Public Health and Institute of State Governance, Sun Yat-sen University, Guangzhou, China.
  • Key Laboratory of Health Informatics of Guangdong Province, Sun Yat-sen University, Guangzhou, China.
  • Department of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing, China.
  • Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China. gujing5@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • National Major Science and Technology Projects of China

Zitieren

APA

Xie, J., Wang, X., Wang, X., Li, J., Jie, Y., Hao, Y., & Gu, J. (2024). Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study. Global Health Research and Policy. https://doi.org/10.1186/s41256-024-00345-2

Vancouver

Xie J, Wang X, Wang X, Li J, Jie Y, Hao Y, et al. Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study. Global Health Research and Policy. 2024. doi:10.1186/s41256-024-00345-2

BibTeX
@article{Xie2024,
  author = {Xie, Jinzhao and Wang, Xu and Wang, Xinran and Li, Jinghua and Jie, Yusheng and Hao, Yuantao and Gu, Jing},
  title = {Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study},
  journal = {Global Health Research and Policy},
  year = {2024},
  doi = {10.1186/s41256-024-00345-2}
}
Kostenlos starten →